Stromal Expression of MicroRNA-21 in Advanced Colorectal Cancer Patients with Distant Metastases
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: The aim of this study was to determine the regional heterogeneity and clinicopathological significance of microRNA-21 (miR-21) in advanced colorectal cancer (CRC) patients with distant metastasis. Methods: miR-21 expression was investigated by using locked nucleic acid–fluorescence in situ hybridization in the center and periphery of the primary cancer and in distant metastasis from 170 patients with advanced CRC. In addition, α-smooth muscle actin and desmin were evaluated to identify cancer-associated fibroblasts (CAFs) by using immunohistochemistry. Results: The miR-21 signal was observed in the cancer stroma. The expression of miR-21 (a score of 1–4) in the center and periphery of the primary cancer and in distant metastasis was observed in specimens from 133 (78.2%), 105 (61.8%), and 91 (53.5%) patients, respectively. miR-21 expression was heterogeneous in advanced CRC. Discordance between miR-21 expression in the center of the primary cancer and either the periphery of the primary cancer or distant metastasis was 31.7% or 44.7%, respectively. miR-21 stromal expression in the periphery of the primary cancer was significantly associated with a better prognosis (p = .004). miR-21 expression was significantly associated with CAFs in the center of the primary cancer (p = .001) and distant metastases (p = .041). Conclusions: miR-21 expression is observed in cancer stroma related to the CAF quantity and frequently presents regional heterogeneity in CRC. Our findings indicate that the role of miR-21 in predicting prognosis may be controversial but provide a new perspective of miR-21 level measurement in cancer specimens.
Abstract
Background: The aim of this study was to determine the regional heterogeneity and clinicopathological significance of microRNA-21 (miR-21) in advanced colorectal cancer (CRC) patients with distant metastasis. Methods: miR-21 expression was investigated by using locked nucleic acid–fluorescence in situ hybridization in the center and periphery of the primary cancer and in distant metastasis from 170 patients with advanced CRC. In addition, α-smooth muscle actin and desmin were evaluated to identify cancer-associated fibroblasts (CAFs) by using immunohistochemistry. Results: The miR-21 signal was observed in the cancer stroma. The expression of miR-21 (a score of 1–4) in the center and periphery of the primary cancer and in distant metastasis was observed in specimens from 133 (78.2%), 105 (61.8%), and 91 (53.5%) patients, respectively. miR-21 expression was heterogeneous in advanced CRC. Discordance between miR-21 expression in the center of the primary cancer and either the periphery of the primary cancer or distant metastasis was 31.7% or 44.7%, respectively. miR-21 stromal expression in the periphery of the primary cancer was significantly associated with a better prognosis (p = .004). miR-21 expression was significantly associated with CAFs in the center of the primary cancer (p = .001) and distant metastases (p = .041). Conclusions: miR-21 expression is observed in cancer stroma related to the CAF quantity and frequently presents regional heterogeneity in CRC. Our findings indicate that the role of miR-21 in predicting prognosis may be controversial but provide a new perspective of miR-21 level measurement in cancer specimens.
참고문헌 (41)
- Carrington JC, "Role of microRNAs in plant and animal development", Science, 301, pp.336~338 (2003)
- Zhang B, "microRNAs as oncogenes and tumor suppressors", Dev Biol, 302, pp.1~12 (2007)
- Kwak PB, "The microRNA pathway and cancer", Cancer Sci, 101, pp.2309~2315 (2010)
- Chan SH, "miR-21 microRNA expression in human gastric carcinomas and its clinical association", Anticancer Res, 28, pp.907~911 (2008)
- Gabriely G, "MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators", Mol Cell Biol, 28, pp.5369~5380 (2008)
- Qian B, "High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1", Breast Cancer Res Treat, 117, pp.131~140 (2009)
- Markou A, "Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR", Clin Chem, 54, pp.1696~1704 (2008)
- Zhang A, "miR-21 modulates cell apoptosis by targeting multiple genes in renal cell carcinoma", Urology, 78, pp.474~ (2011)
- Hiyoshi Y, "MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma", Clin Cancer Res, 15, pp.1915~1922 (2009)
- Asangani IA, "MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4and stimulates invasion, intravasation and metastasis in colorectal cancer", Oncogene, 27, pp.2128~2136 (2008)
- Lu Z, "MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene", Oncogene, 27, pp.4373~4379 (2008)
- Mathé EA, "MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus:associations with survival", Clin Cancer Res, 15, pp.6192~6200 (2009)
- Yan LX, "MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis", RNA, 14, pp.2348~2360 (2008)
- Yu Y, "miR-21 and miR-145 cooperation in regulation of colon cancer stem cells", Mol Cancer, 14, pp.98~ (2015)
- Kanaan Z, "Plasma miR-21: a potential diagnostic marker of colorectal cancer", Ann Surg, 256, pp.544~551 (2012)
- Ng EK, "Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening", Gut, 58, pp.1375~1381 (2009)
- Huang Z, "microRNAs are promising novel biomarkers for early detection of colorectal cancer", Int J Cancer, 127, pp.118~126 (2010)
- Yu Y, "Down-regulation of miR-21 induces differentiation of chemoresistant colon cancer cells and enhances susceptibility to therapeutic regimens", Transl Oncol, 6, pp.180~186 (2013)
- Valeri N, "MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)", Proc Natl Acad Sci U S A, 107, pp.21098~21103 (2010)
- Xia X, "Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis", PLoS One, 8, pp.E80426~ (2013)
- Kjaer-Frifeldt S, "The prognostic importance of miR-21 in stage II colon cancer: a population-based study", Br J Cancer, 107, pp.1169~1174 (2012)
- Kang WK, "Stromal expression of miR-21 in T3-4a colorectal cancer is an independent predictor of early tumor relapse", BMC Gastroenterol, 15, pp.2~ (2015)
- Zhang JX, "Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA ex pression analysis", Lancet Oncol, 14, pp.1295~1306 (2013)
- Nielsen BS, "High levels of microRNA-21in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients", Clin Exp Metastasis, 28, pp.27~38 (2011)
- Kwak Y, "The clinical implication of cancer-associated microvasculature and fibroblast in advanced colorectal cancer patients with synchronous or metachronous metastases", PLoS One, 9, pp.E91811~ (2014)
- Tsujino T, "Stromal myofibroblasts predict disease recurrence for colorectal cancer", Clin Cancer Res, 13, pp.2082~2090 (2007)
- Trimboli AJ, "Pten in stromal fibroblasts suppresses mammary epithelial tumours", Nature, 461, pp.1084~1091 (2009)
- Knijn N, "Current issues in the targeted therapy of advanced colorectal cancer", Discov Med, 9, pp.328~336 (2010)
- O’Connell MJ, "Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set", J Clin Oncol, 26, pp.2336~2341 (2008)
- Albanese I, "Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations", Biochem Biophys Res Commun, 325, pp.784~791 (2004)
- Park JH, "Analysis of KRAS, BRAF, PTEN, IGF1R, EGFR intron 1 CA status in both primary tumors and paired metastases in determining benefit from cetuximab therapy in colon cancer", Cancer Chemother Pharmacol, 68, pp.1045~1055 (2011)
- Baldus SE, "Prevalence and heterogeneity of KRAS, BRAF, and PIK-3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases", Clin Cancer Res, 16, pp.790~799 (2010)
- Villegas-Ruiz V, "Heterogeneity of microRNAs expression in cervical cancer cells: overexpression of miR-196a", Int J Clin Exp Pathol, 7, pp.1389~1401 (2014)
- Jepsen RK, "Intra-tumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer", Exp Mol Pathol, 100, pp.125~131 (2016)
- Raychaudhuri M, "Intratumoral heterogeneity of microRNA expression in breast cancer", J Mol Diagn, 14, pp.376~384 (2012)
- Bullock MD, "Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression", Cell Death Dis, 4, pp.E684~ (2013)
- Yamamichi N, "Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development", Clin Cancer Res, 15, pp.4009~4016 (2009)
- Shenouda SK, "MicroRNA function in cancer: oncogene or a tumor suppressor?", Cancer Metastasis Rev, 28, pp.369~378 (2009)
- Fassan M, "PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis", Virchows Arch, 458, pp.413~419 (2011)
- Aprelikova O, "MicroRNA regulation in cancer-associated fibroblasts", Cancer Immunol Immunother, 61, pp.231~237 (2012)
- Lou E, "Pancreatic cancer: modulation of KRAS, microRNAs, and intercellular communication in the setting of tumor heterogeneity", Pancreas, 42, pp.1218~1226 (2013)